Department of Dermatology and Allergy, University of Bonn, Bonn, Germany.
Clin Exp Immunol. 2010 Jul 1;161(1):28-33. doi: 10.1111/j.1365-2249.2010.04162.x. Epub 2010 Apr 9.
Recent progress achieved by an impressive number of studies focusing upon the ontogenesis and immunobiology of epidermal Langerhans cells (LCs) and other cutaneous dendritic cell (DC) populations as well as DCs at oral mucosal tissue has profoundly revised our understanding of the role of DCs in different tissues and microenvironments. By sensing their environment for microbial signals or allergens and bridging innate and adaptive immunity in a sophisticated manner, subtypes of DCs play a critical role in the maintenance of the immunological homeostasis in the periphery. Thereby, DCs, located directly at the interface to the environment, fulfil opposing tasks as they are key players in both the control and the generation of allergic inflammation. Furthermore, it is under ongoing debate whether DCs attenuate or aggravate allergic inflammation. As a consequence, accumulated knowledge gained in this field within the last few years has provided an excellent basis for innovative therapeutic opportunities which tend to target specifically the multi-faceted properties of DCs at distinct anatomical sites.
近年来,大量研究集中于表皮朗格汉斯细胞(LCs)和其他皮肤树突状细胞(DC)群体以及口腔黏膜组织中的 DC 的个体发生和免疫生物学,这些研究取得了令人瞩目的进展,极大地改变了我们对 DC 在不同组织和微环境中作用的认识。通过以复杂的方式感知其环境中的微生物信号或过敏原,并桥接先天免疫和适应性免疫,DC 的亚群在维持外周免疫稳态方面发挥着关键作用。因此,位于与环境直接交界的 DC 履行着相反的任务,因为它们是控制和产生过敏炎症的关键因素。此外,DC 是减轻还是加重过敏炎症仍存在争议。因此,近年来在该领域积累的知识为创新治疗机会提供了极好的基础,这些机会倾向于针对特定解剖部位的 DC 的多方面特性进行特异性靶向。